Inventor · disambiguated record
Shunqi Yan
Also filed as: YAN SHUNQI
32 granted patents·22 pending applications·239 citations·filing 2006–2024
97Inventor score
Files withAGIOS PHARMACEUTICALS INC19ARTHROSI THERAPEUTICS INC15SALITURO FRANCESCO G5PHARMACYCLICS LLC4ARDEA BIOSCIENCES2
Top patents by PatentIndex Score
54 records- 0198US8785450B2Therapeutic compounds and compositionsSALITURO FRANCESCO G·Filed 2010·Granted Jul 22, 2014·45 cites·51 claims
- 0297US9512107B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Dec 6, 2016·25 cites·9 claims
- 0397US8889667B2Therapeutic compounds and compositionsSALITURO FRANCESCO G·Filed 2011·Granted Nov 18, 2014·28 cites·11 claims
- 0496US10029987B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2017·Granted Jul 24, 2018·9 cites·24 claims
- 0596US9656999B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted May 23, 2017·16 cites·4 claims
- 0694US9732062B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Aug 15, 2017·18 cites·6 claims
- 0793US10239854B2Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemiaARTHROSI THERAPEUTICS INC·Filed 2018·Granted Mar 26, 2019·7 cites·20 claims
- 0893US9199968B2Therapeutic compounds and compositionsSALITURO FRANCESCO G·Filed 2014·Granted Dec 1, 2015·10 cites·16 claims
- 0991US10508093B2Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemiaARTHROSI THERAPEUTICS INC·Filed 2019·Granted Dec 17, 2019·4 cites·20 claims
- 1091US9221792B2N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulatorsSALITURO FRANCESCO G·Filed 2011·Granted Dec 29, 2015·17 cites·14 claims
- 1190US10294215B2Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Granted May 21, 2019·6 cites·32 claims
- 1289US12428376B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2023·Granted Sep 30, 2025·0 cites·5 claims
- 1389US7897624B2Pyridone sulfonamides and pyridone sulfamides as MEK inhibitorsARDEA BIOSCIENCES·Filed 2007·Granted Mar 1, 2011·16 cites·18 claims
- 1488US7842836B2N-aryl-N'alkyl sulfamides as MEK inhibitorsARDEA BIOSCIENCES·Filed 2007·Granted Nov 30, 2010·7 cites·17 claims
- 1587US11236058B2Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemiaARTHROSI THERAPEUTICS INC·Filed 2019·Granted Feb 1, 2022·2 cites·9 claims
- 1686US11505538B1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Nov 22, 2022·1 cites·8 claims
- 1785US9708326B2Inhibitors of bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2014·Granted Jul 18, 2017·4 cites·18 claims
- 1884US2024116888A1Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemiaARTHROSI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1983US9303002B2Compounds and their methods of useLEMIEUX RENE M·Filed 2013·Granted Apr 5, 2016·6 cites·15 claims
- 2082US9469642B2Purinone compounds as kinase inhibitorsPHARMACYCLICS LLC·Filed 2013·Granted Oct 18, 2016·4 cites·2 claims
- 2182US2023250078A1Therapeutically active compounds and their methods of useSERVIER PHARMACEUTICALS LLC·Filed 2022·Application pending·0 cites
- 2282US2023227419A1Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemiaARTHROSI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2379US2022396558A1Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemiaARTHROSI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2478US12145917B2Crystalline forms of a compound for treating or preventing gout or hyperuricemiaARTHROSI THERAPEUTICS INC·Filed 2019·Granted Nov 19, 2024·1 cites·18 claims
- 2577US11866411B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2021·Granted Jan 9, 2024·0 cites·10 claims
- 2677USRE49582ETherapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2020·Granted Jul 18, 2023·0 cites·57 claims
- 2777US9856279B2Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Granted Jan 2, 2018·1 cites·26 claims
- 2876US10988448B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2019·Granted Apr 27, 2021·0 cites·5 claims
- 2976US8716318B2Pyridone sulfonamides and pyridone sulfamides as MEK inhibitorsYAN SHUNQI·Filed 2011·Granted May 6, 2014·5 cites·18 claims
- 3076US2022112171A1Compounds, compositions and methods for treating or preventing a symptom associated with gout or hyperuricemiaARTHROSI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3174US9580416B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2015·Granted Feb 28, 2017·2 cites·18 claims
- 3272US10011574B2Glutaminase inhibitors and method of useAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Jul 3, 2018·1 cites·8 claims
- 3369US10202339B2Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2013·Granted Feb 12, 2019·1 cites·11 claims
- 3469US9662327B2Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancerCAO SHELDON·Filed 2012·Granted May 30, 2017·2 cites·22 claims
- 3569US2019241523A1Therapeutic compounds and compositionsAGIOS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 3669US2014323467A1Therapeutic compounds and compositionsSALITURO FRANCESCO G·Filed 2014·Application pending·0 cites
- 3769US2020079755A1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 3866US8673919B2Dihydropyridin sulfonamides and dihydropyridin sulfamides as MEK inhibitorsVERNIER JEAN-MICHEL·Filed 2010·Granted Mar 18, 2014·1 cites·22 claims
- 3965US2025059150A1Crystalline forms of a compound for treating or preventing gout or hyperuricemiaARTHROSI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4058US10414740B2Glutaminase inhibitors and method of useAGIOS PHARMACEUTICALS INC·Filed 2018·Granted Sep 17, 2019·0 cites·19 claims
- 4156US2025066316A1Crystalline forms of a compound for treating or preventing gout or hyperuricemiaARTHROSI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4254US12419854B2Methods for treating or preventing gout or hyperuricemiaARTHROSI THERAPEUTICS INC·Filed 2019·Granted Sep 23, 2025·0 cites·8 claims
- 4353US2025243171A1Quinazoline compounds for treatment of diseaseARTHROSI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4453US2025100988A1Preparation of a compound for the treatment of gout or hyperuricemiaARTHROSI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4552US2016264621A1Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4651US2016368924A1Purinone compounds as kinase inhibitorsPHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
- 4749US2015087600A1Therapeutically active compounds and their methods of usePOPOVICI-MULLER JANETA·Filed 2013·Application pending·0 cites
- 4848US2017210749A1Therapeutically active compositions and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 4946US2013184222A1Therapeutically active compositions and their methods of usePOPOVICI-MULLER JANETA·Filed 2011·Application pending·0 cites
- 5046US2016304556A1Therapeutically active compounds and their methods of useAGIOS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Shunqi Yan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →